Literature DB >> 10837395

Conjunctival epithelium expression of HLA-DR in glaucoma patients and its influence on the outcome of filtration surgery.

A Ihan1, B Cvenkel.   

Abstract

AIMS: To analyse the expression of HLA-DR on conjunctival epithelial cells in patients with glaucoma taking topical antiglaucoma therapy.
METHODS: 10 patients taking no topical medication and 30 patients with uncontrolled glaucoma taking medical therapy participated in the study. The specimens were obtained by impression cytology preoperatively, 3 months, and 6 months after filtration surgery. The expression of HLA-DR on T lymphocytes and epithelial cells was analysed by flow cytometry.
RESULTS: A significant increase in HLA-DR on epithelial cells was found preoperatively in patients with glaucoma. A significant increased expression of HLA-DR on epithelial cells was detected 3 months and 6 months after surgery.
CONCLUSIONS: The increased expression of HLA-DR on conjunctival epithelial cells still present 6 months after surgery indicates the increased ability of epithelial cells to induce immune inflammation with subsequent fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837395      PMCID: PMC1723488          DOI: 10.1136/bjo.84.6.648

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Long-term follow-up of initially successful trabeculectomy.

Authors:  T C Chen; J T Wilensky; M A Viana
Journal:  Ophthalmology       Date:  1997-07       Impact factor: 12.079

2.  The influence of prior therapy on the success of trabeculectomy.

Authors:  M J Lavin; R P Wormald; C S Migdal; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1990-11

3.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

4.  Long-term results of trabeculectomy in the Japanese: an analysis by life-table method.

Authors:  Z Inaba
Journal:  Jpn J Ophthalmol       Date:  1982       Impact factor: 2.447

5.  Clinico pathological correlation in eyes with failed fistulizing surgery.

Authors:  R A Hitchings; I Grierson
Journal:  Trans Ophthalmol Soc U K       Date:  1983

Review 6.  Wound healing in glaucoma filtering surgery.

Authors:  G L Skuta; R K Parrish
Journal:  Surv Ophthalmol       Date:  1987 Nov-Dec       Impact factor: 6.048

7.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

8.  Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma.

Authors:  C Baudouin; C Garcher; N Haouat; A Bron; P Gastaud
Journal:  Ophthalmology       Date:  1994-03       Impact factor: 12.079

  8 in total
  4 in total

1.  Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?

Authors:  M Souchier; N Buron; P O Lafontaine; A M Bron; C Baudouin; C Creuzot-Garcher
Journal:  Br J Ophthalmol       Date:  2006-06-29       Impact factor: 4.638

2.  Is post-trabeculectomy hypotony a risk factor for subsequent failure? A case control study.

Authors:  Sarah E Benson; Kaveri Mandal; Catey V Bunce; Scott G Fraser
Journal:  BMC Ophthalmol       Date:  2005-04-05       Impact factor: 2.209

3.  Conjunctival TGF-B Level in Primary Augmented Trabeculectomy.

Authors:  Guan Fook Ng; Ishak Siti Raihan; Yaakub Azhany; Che Hussin Che Maraina; K Gurusamy Banumathi; Tajudin Liza-Sharmini
Journal:  Open Ophthalmol J       Date:  2015-07-31

4.  The ocular surface after successful glaucoma filtration surgery: a clinical, in vivo confocal microscopy, and immune-cytology study.

Authors:  Luca Agnifili; Lorenza Brescia; Francesco Oddone; Matteo Sacchi; Erminia D'Ugo; Guido Di Marzio; Fabiana Perna; Ciro Costagliola; Rodolfo Mastropasqua
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.